Hal W. Hirte, MD, FRCPC
Hal W. Hirte, MD, FRCPC
Associate Professor
McMaster University
699 Concession Street
Hamilton,
ON
Canada
L8V 5C2
Papers:
3 - Seminal Abstract
Randomized double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum-sensitive ovarian cancer: results of the ICON6 trial